Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
De Koning TJ, Klomp LW, van Oppen AC et al (2004) Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency. Lancet 364: 2221–2222
Van Spronsen FJ, Smit GPA, Erwich JJHM (2005) Inherited metabolic diseases and pregnancy. BJOG: an International Journal of Obstetrics and Gynaecology 112: 2–11
Saudubray JM (2002) Inborn errors of metabolism. Semin Neonatol 7 (issue 1)
Saudubray JM, Nassogne MC, de Lonlay P, Touati G (2002) Clinical approach to inherited metabolic disorders in neonates: an overview. Semin Neonatol 7: 3–15
Jaeken J, Martens K, Francois I et al (2006) Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia cystinuria syndrome. Am J Hum Genet 78: 38–51
Fellman V, Rapola J, Pihko H, Varilo T, Raivio KO (1998) Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis, and aminoaciduria. Lancet 351: 490–493
Visapaa I, Fellman V, Vesa J et al (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71: 863–876
Tazawa Y, Kobayashi K, Abukawa D et al (2004) Clinical heterogeneity of neonatal intrahepatic cholestasis caused by citrin deficiency: case reports from 16 patients. Mol Genet Metab 83: 213–219
Tazawa Y, Abukawa D, Sakamoto O et al (2005) A possible mechanism of neonatal intrahepatic cholestasis caused by citrin deficiency. Hepatol Res 31: 168–171
Saudubray JM, Martin D, De Lonlay P et al (1999) Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 22: 488–502
Bonnet D, Martin D, De Lonlay P, Villain E, Jouvet P, Rabier D, Brivet M, Kachaner J, Saudubray JM (1999) Arrhythmias and conduction defects as a presenting symptom of fatty-acid oxidation disorders in children. Circulation 100: 2248–2253
Ozand PT, Gascon GG, Al Essa M et al (1998) Biotin-responsive basal ganglia disease: a novel entity. Brain 121:1267–1279
Zeng WQ, Al-Yamani E, Acierno JS et al (2005) Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in the SLC19A3 gene. Am J Hum Genet 77:16–26
Tiranti V, d’Adamo P, Briem E et al (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74: 239–252
Sasaki M, Kimura M, Sugai K, Hashimoto T, Yamaguchi S (1998) 3-Hydroxyisobutyric aciduria in two brothers. Pediatr Neurol 18: 253–255
Boles RG, Chun N, Senadheera D, Wong LJC (1997) Cyclic vomiting syndrome and mitochondrial DNA mutations. Lancet 350: 1299–1300
Chinnery PF, Turnbull DM (1997) Vomiting, anorexia, and mitochondrial DNA disease. Lancet 6351: 448
Curtis A, Fey C, Morris C et al (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28: 350–354
Maciel P, Cruz VT, Constante M et al (2005) Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement. Neurology 65: 603–605
Bennett MJ, Weinberger MJ, Kobori JA, Rinaldo P, Burlina AB (1996) Mitochondrial short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: a new defect of fatty acid oxidation. Pediatr Res 39: 185–188
Pelletier VA, Galeano N, Brochu P, Morin CL, Weber AM, Roy CC (1986) Secretory diarrhea with protein-losing enteropathy, enterocolitis cystica superficialis, intestinal lymphangiectasia, and congenital hepatic fibrosis: a new syndrome. J Pediatr 108: 61–65
Vuillaumier-Barrot S, Le Bizec C, de Lonlay P et al (2002) Protein losing enteropathy-hepatic fibrosis syndrome in Saguenay-Lac St-Jean, Quebec is a congenital disorder of glycosylation type Ib. J Med Genet 39: 849–851
Schwartz CE, May MM, Carpenter NJ et al (2005) Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCD8) gene. Am J Hum Genet 77:41–53
Van Coster R, Lissens W, Giardina T et al (2005) An infant with large amounts of several N-acetylated amino acids in the urine has aminoacylase I deficiency. J Inherit Metab Dis 28(Suppl 1): 50
Sass JO, Mohr V, Olbrich H et al (2006) Mutations in ACY1, the gene encoding aminocyclase 1, cause a novel inborn error of metabolism. Am J Hum Genet 78: 401–409
Lyon G, Adams RD, Kolodny EH (1996) Neurology of hereditary metabolic diseases of children, 2nd edn. McGraw-Hill, New York
Ramaekers VT, Rothenberg SP, Sequeira JM et al (2005) Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 352: 1985–1991
Poll-The BT, Saudubray JM, Ogier H et al (1986) Infantile Refsum’s disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis 9: 169–174
Deodato F, Brancati F, Valente EM et al (2005) MAMEL (Methylmalonic Aciduria Mitochondrial Encephalopathy Leigh-like): a new mitochondrial encephalopathy. J Inherit Metab Dis 28(Suppl 1):130
Straussberg R, Shorer Z, Weitz R et al (2002) Familial infantile bilateral striatal necrosis: clinical features and response to biotin treatment. Neurology 59: 983–989
Sprecher E, Ishida-Yamamoto A, Mizrahi-Koren M et al (2005) A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma. Am J Hum Genet 77:242–251
Gollob MH (2003) Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndrome. Biochem Soc Trans 31: 228–231
Arad M, Maron BJ, Gorham JM et al (2005) Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352: 362–72
Holme E, Kollberg G, Oldfors A, Gilljam T, Tulinius M (2005) Muscular glycogen storage disease 0: a new disease entity in a child with hypertrophic cardiomyopathy and myopathy due to a homozygous stop mutation in the muscular glycogen synthase gene (GYS1). J Inherit Metab Dis 28(Suppl 1): 214
Wolf NI, Harting I, Boltshauser E et al (2005) Leucoencephalopathy with ataxia, hypodontia and hypomyelination. Neurology 64: 1461–1464
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Saudubray, JM., Desguerre, I., Sedel, F., Charpentier, C. (2006). A Clinical Approach to Inherited Metabolic Diseases. In: Fernandes, J., Saudubray, JM., van den Berghe, G., Walter, J.H. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-28785-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-540-28785-8_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28783-4
Online ISBN: 978-3-540-28785-8
eBook Packages: MedicineMedicine (R0)